Literature DB >> 7256184

Plasma high-density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment.

P V Luoma, E A Sotaniemi, R O Pelkonen, V V Myllylä.   

Abstract

Relation of plasma high-density lipoprotein (HDL) cholesterol concentration to hepatic microsomal enzyme activity in eighteen epileptics with diagnostic liver biopsy was investigated, the cytochrome P-450 content in biopsy samples being used to reflect the liver enzyme activity. A significant correlation (r = 0.67, P less than 0.01) was found. Combination therapy with anticonvulsants was associated with higher plasma HDL cholesterol and hepatic cytochrome P-450 concentrations than the treatment with phenytoin alone. Serum triglyceride level was inversely related to the hepatic cytochrome P-450 content (r = 0.62, P less than 0.01). Plasma HDL cholesterol and hepatic cytochrome P-450 were related to liver histology. Patients with hepatic fatty infiltration had low HDL cholesterol and cytochrome P-450 concentrations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7256184     DOI: 10.3109/00365518009093020

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  7 in total

1.  One year study of effects of an oestrogen-dominant oral contraceptive on serum high-density lipoprotein cholesterol, apolipoproteins A-I and A-II and hepatic microsomal function.

Authors:  P V Luoma; J E Heikkinen; C Ehnholm; P R Ylöstalo
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

2.  Serum selenium, glutathione peroxidase, lipids, and human liver microsomal enzyme activity : A double-blind controlled trial of selenium supplementation.

Authors:  P V Luoma; H Korpela; E A Sotaniemi; J Kumpulainen
Journal:  Biol Trace Elem Res       Date:  1985-09       Impact factor: 3.738

3.  Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes.

Authors:  P V Luoma; E A Sotaniemi; R O Pelkonen; H I Pirttiaho
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 4.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

6.  QTL/microarray approach using pathway information.

Authors:  Hirokazu Matsuda; Yukio Taniguchi; Hiroaki Iwaisaki
Journal:  Algorithms Mol Biol       Date:  2012-01-15       Impact factor: 1.405

Review 7.  PXR and 4β-Hydroxycholesterol Axis and the Components of Metabolic Syndrome.

Authors:  Janne Hukkanen; Jukka Hakkola
Journal:  Cells       Date:  2020-11-09       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.